Iranian Journal of Public Health 2017. 46(11):1598-1600.

Molecular Diagnostics with Laboratory Finding in Patients with Myeloproliferative Neoplasms
Zahra MAKANI, Sina MIRZAAHMADI, Marzieh MOTALLEBI, Abolfazl MOVAFAGH

Abstract


Molecular Diagnostics with Laboratory Finding in Patients with Myeloproliferative Neoplasms

Keywords


No keywords##

Full Text:

PDF

References


Tefferi A, Vardiman JW (2008). Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia, 22(1):14-22.

Scott LM (2011). The JAK2 exon 12 mutations: a comprehensive review. Am J Hematol, 86(8):668-76.

Movafagh A, Maleki F, Fadaie S, et al (2007). Persistent unstable chromosomal aberration in lymphocytes of radiotherapy workers after 1st mitotic division in Tehran, Iran. Pak J Med Sci, 23(2):254-258.

Pardanani A, Lasho TL, Finke C, Hanson CA, Tefferi A (2007). Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia, 21(9):1960-3.

Pietra D, Li S, Brisci A, Passamonti F, Rumi E, Theocharides A, et al (2008). Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood, 111(3):1686-9.

Huang Q, Li X, Chen W, Weiss LM (2007). Absence of JAK-2V617F point mutations in multiple myeloma. Leukemia, 21(4): 813-4.

Movafagh A, Mirfakhraei R, Mousavi-Jarrahi A et al (2011). Frequent incidence of double minute chromosomes in cancers, with special up-to-date reference to leukemia. Asian Pac J Cancer Prev, 12(12):3453-6.

Puigdecanet E, Espinet B, Lozano JJ, et al (2008). Gene expression profiling distin-guishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia. Leukemia, 22(7):1368-76.

Williams DM, Kim AH, Rogers O, Spivak JL, Moliterno AR (2007). Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis. Exp Hematol, 35(11):1641-6.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.